Patent ID: 11912999
Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 17:
18. A method of treating cancer or a microbial infection, comprising administering to a subject in need thereof, a pharmaceutically effective amount of the aptamer-NHCM conjugate of claim 1, selected from the group of 1-(anthracene-9-ylmethyl)-3-(4-N-sgc8c-aptamer-carbamoylbenzyl)benzo[d]imidazolium gold(I) chloride (sgc8c-27), 1-(anthracene-9-ylmethyl)-3-(4-N-AS1411-aptamer-carbamoylbenzyl)benzo[d]imidazolium triphenylphosphino gold(I) tetrafluoroborate (AS1411-29), and a combination thereof.